Journey Medical Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US48115J1097
USD
6.63
-0.87 (-11.6%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Fortress Biotech, Inc.
Bolt Biotherapeutics, Inc.
Sol-Gel Technologies Ltd.
Journey Medical Corp.
CASI Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc.
vTv Therapeutics, Inc.
NextCure, Inc.
Lantern Pharma, Inc.
Daré Bioscience, Inc.
Kineta, Inc.

Why is Journey Medical Corp. ?

1
Poor long term growth as Operating profit has grown by an annual rate -218.90% of over the last 5 years
2
The company has declared Negative results for the last 4 consecutive quarters
  • INTEREST(HY) At USD 1.87 MM has Grown at 41.86%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 24.39%, its profits have risen by 55.5%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Journey Medical Corp. for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Journey Medical Corp.
24.39%
0.29
63.67%
S&P 500
14.9%
0.77
19.29%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-43.17%
EBIT Growth (5y)
-218.90%
EBIT to Interest (avg)
-3.60
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.19
Sales to Capital Employed (avg)
2.20
Tax Ratio
0.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
43.72%
ROCE (avg)
97.82%
ROE (avg)
60.98%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.57
EV to EBIT
-24.69
EV to EBITDA
-42.70
EV to Capital Employed
9.47
EV to Sales
4.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-38.34%
ROE (Latest)
-33.45%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET PROFIT(HY)

Higher at USD -6.11 MM

NET SALES(Q)

Highest at USD 17.63 MM

OPERATING PROFIT(Q)

Highest at USD -0.44 MM

OPERATING PROFIT MARGIN(Q)

Highest at -2.51 %

-4What is not working for the Company
INTEREST(HY)

At USD 1.87 MM has Grown at 41.86%

Here's what is working for Journey Medical Corp.

Net Profit
Higher at USD -6.11 MM
than preceding 12 month period ended Sep 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Net Sales
Highest at USD 17.63 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Sales
At USD 17.63 MM has Grown at 25.05%
over average net sales of the previous four periods of USD 14.1 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD -0.44 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at -2.51 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Here's what is not working for Journey Medical Corp.

Interest
At USD 1.87 MM has Grown at 41.86%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)